| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mirati Therapeutics, Inc. | SVP, Chief Accounting Officer | Common Stock | 15.4K | $907K | $59.02 | Jan 18, 2022 | Direct |
| Adamis Pharmaceuticals Corp | Director | Stock Appreciation Right | 50K | May 24, 2022 | Direct | ||
| Evoke Pharma Inc | Director | Stock Option (Right to Buy) | 15K | May 22, 2024 | Direct | ||
| Mirati Therapeutics, Inc. | SVP, Chief Accounting Officer | Employee Stock Option (Right to Buy) | 8.91K | Jan 14, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EVOK | Evoke Pharma Inc | May 22, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| EVOK | Evoke Pharma Inc | May 10, 2023 | 1 | $0 | 4 | May 11, 2023 | Director |
| ADMP | Adamis Pharmaceuticals Corp | May 24, 2022 | 0 | $0 | 3 | May 26, 2022 | Director |
| ADMP | Adamis Pharmaceuticals Corp | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| EVOK | Evoke Pharma Inc | Apr 27, 2022 | 1 | $0 | 4 | Apr 28, 2022 | Director |
| MRTX | Mirati Therapeutics, Inc. | Jan 14, 2022 | 3 | -$64.2K | 4 | Jan 18, 2022 | SVP, Chief Accounting Officer |
| MRTX | Mirati Therapeutics, Inc. | Jan 7, 2022 | 1 | -$46.9K | 4 | Jan 7, 2022 | SVP, Chief Accounting Officer |
| MRTX | Mirati Therapeutics, Inc. | Jan 4, 2022 | 1 | -$112K | 4 | Jan 6, 2022 | SVP, Chief Accounting Officer |
| EVOK | Evoke Pharma Inc | May 13, 2021 | 1 | $0 | 4 | May 17, 2021 | Director |
| EVOK | Evoke Pharma Inc | May 13, 2021 | 0 | $0 | 3 | May 17, 2021 | Director |